AHMED NADIM - Insider Non-Derivative Transactions at Cullinan Therapeutics, Inc. (CGEM) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 23, 2025, AHMED NADIM's relationship to Cullinan Therapeutics, Inc. (CGEM) is Director,Officer (President and CEO), and currently has 420,699 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CGEM insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

AHMED NADIM - Insider Non-Derivative Transactions of CGEM Common Stock

AHMED NADIM - Insider Non-Derivative Transactions at CGEM

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 24, 2025	Sell -- (Common Stock)	9922	10.01	420699
Feb 26, 2025	Sell -- (Common Stock)	12529	8.53	430621
Feb 20, 2025	Acquisition -- (Common Stock)	180000	0	443150
Dec 25, 2024	Sell -- (Common Stock)	8400	11.87	263150
Feb 23, 2024	Acquisition -- (Common Stock)	160000	0	271550
Dec 27, 2023	Sell -- (Common Stock)	4272	9.24	111550
Jun 29, 2023	Sell -- (Common Stock)	759	11.4	115822
May 24, 2023	Sell -- (Common Stock)	707	9.15	116581
Apr 26, 2023	Sell -- (Common Stock)	716	10.59	117288
Mar 24, 2023	Sell -- (Common Stock)	706	10.51	118004
Feb 23, 2023	Acquisition -- (Common Stock)	109000	0	118710